Lignocaine use in respiratory viruses | Zendy

Tariq Hayat Khan | Zendy; Amjid Hammodi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Lignocaine use in respiratory viruses

Author(s) -

Tariq Hayat Khan,

Amjid Hammodi

Publication year - 2020

Publication title -

anaesthesia pain and intensive care

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.17

H-Index - 8

eISSN - 2220-5799

pISSN - 1607-8322

DOI - 10.35975/apic.v24i4.1332

Subject(s) - respiratory system , medicine , covid-19 , anesthesia , intensive care medicine , pain management , remedial education , psychology , disease , infectious disease (medical specialty) , mathematics education

Following the publication of the article entitled, ‘Lignocaine’s substantial role in COVID-19 management: potential remedial and therapeutic implications’, authored by Nasser Ali Malik, Amjid Hammodi and Dayanidhi Jaiswara, published in the Anaesthesia, Pain and Intensive Care; 21(1);59-63, 2020, I would like to suggest a revolutionary idea that could help control the spread of respiratory viruses from person to person, achieve potential prophylaxis against them and even could be used as a treatment for mild to moderately infected cases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research